Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?

被引：0
|
作者：
Childs, Daniel S. [1 ]
Orme, Jacob J. [1 ]
Ravi, Praful [2 ]
机构：
[1] Mayo Clin, Dept Oncol, 200 First St SW, Rochester, MN 55905 USA
[2] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 10期
关键词：
ABIRATERONE ACETATE; ENZALUTAMIDE; INTERMITTENT; SURVIVAL; RISK;
D O I：
10.1200/JCO.23.02410
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay
    Ellis, WJ
    Vessella, RL
    Noteboom, JL
    Lange, PH
    Wolfert, RL
    Rittenhouse, HG
    UROLOGY, 1997, 50 (04) : 573 - 579
  • [32] Nadir prostate-specific antigen as a predictor of progression to an drogen-independent prostate cancer
    Benaim, EA
    Pace, CM
    Lam, PM
    Roehrborn, CG
    UROLOGY, 2002, 59 (01) : 73 - 78
  • [33] Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific Antigen
    Lee, Dong Kil
    Park, Jeong Hyun
    Kim, Jae Han
    Lee, Seung Joon
    Jo, Moon Ki
    Gil, Myung Cheol
    Song, Kang Hyon
    Park, Jong Wook
    KOREAN JOURNAL OF UROLOGY, 2010, 51 (05) : 358 - 361
  • [34] Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level
    Leibovici, Dan
    Spiess, Philippe E.
    Agarwal, Piyush K.
    Tu, Shi-Ming
    Pettaway, Curtis A.
    Hitzhusen, Kate
    Millikan, Randall E.
    Pisters, Louis L.
    CANCER, 2007, 109 (02) : 198 - 204
  • [35] Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer
    Benaim, EA
    Page, CM
    Lam, PM
    Roehrborn, CG
    JOURNAL OF UROLOGY, 2002, 168 (01): : 379 - 379
  • [36] EARLY DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: LOW FREE PROSTATE-SPECIFIC ANTIGEN LEVELS AS A CRITERION FOR PROSTATE BIOPSY IN PATIENTS WITH LOW TOTAL PROSTATE-SPECIFIC ANTIGEN LEVELS
    Sasaki, Mitsuharu
    Ishidoya, Shigeto
    Ito, Akihiro
    Numahata, Kenji
    Shibuya, Daisuke
    Arai, Yoichi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E715 - E715
  • [37] Prostate-specific antigen density adjusted for the transition zone for staging clinically localized prostate cancer in Japanese patients with intermediate serum prostate-specific antigen levels
    Furuya, Y
    Ohta, S
    Sato, N
    Kotake, T
    Sugano, I
    Nagao, K
    Masai, M
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1317 - 1320
  • [38] Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
    Ghafoori, Mahyar
    Varedi, Peyman
    Hosseini, Seyed Jalil
    Asgari, Mojgan
    Shakiba, Madjid
    UROLOGY JOURNAL, 2009, 6 (03) : 182 - 188
  • [39] Prostate-Specific Antigen, Prostate Cancer, and Diabetes Mellitus
    Ming, Chen
    DIABETES, 2017, 66 : A481 - A481
  • [40] Prostate-specific Membrane Antigen PET in Prostate Cancer
    Lawhn-Heath, Courtney
    Salavati, Ali
    Behr, Spencer C.
    Rowe, Steven P.
    Calais, Jeremie
    Fendler, Wolfgang P.
    Eiber, Mattias
    Emmett, Louise
    Hofman, Michael S.
    Hope, Thomas A.
    RADIOLOGY, 2021, 299 (02) : 248 - 260
12345